Literature DB >> 10817692

Resistance to macrolides in Streptococcus pyogenes in France in pediatric patients.

E Bingen1, F Fitoussi, C Doit, R Cohen, A Tanna, R George, C Loukil, N Brahimi, I Le Thomas, D Deforche.   

Abstract

A total of 1,500 recent throat isolates of Streptococcus pyogenes collected between 1996 and 1999 from children throughout France were tested for their susceptibility to erythromycin, azithromycin, josamycin, clindamycin, and streptogramin B. The erythromycin-resistant isolates were further studied for their genetic mechanism of resistance, by means of PCR. The clonality of these strains was also investigated by means of serotyping and ribotyping. In all, 6.2% of the strains were erythromycin resistant, and 3.4 and 2.8% expressed the constitutive MLS(B) and M resistance phenotypes and harbored the ermB and mefA genes, respectively; ermTR was recovered from one isolate which also harbored the ermB gene. Ten serotypes and 8 ribotypes were identified, but we identified 17 strains by combining serotyping with ribotyping. Among the eight ribotypes, the mefA gene was recovered from six clusters, one being predominant, while the ermB gene was recovered from four clusters, of which two were predominant.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10817692      PMCID: PMC89896          DOI: 10.1128/AAC.44.6.1453-1457.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  45 in total

1.  Resistance to erythromycin in group A streptococci.

Authors:  H Seppälä; A Nissinen; H Järvinen; S Huovinen; T Henriksson; E Herva; S E Holm; M Jahkola; M L Katila; T Klaukka
Journal:  N Engl J Med       Date:  1992-01-30       Impact factor: 91.245

Review 2.  Streptococcal M protein: molecular design and biological behavior.

Authors:  V A Fischetti
Journal:  Clin Microbiol Rev       Date:  1989-07       Impact factor: 26.132

Review 3.  Erythromycin resistance by ribosome modification.

Authors:  B Weisblum
Journal:  Antimicrob Agents Chemother       Date:  1995-03       Impact factor: 5.191

4.  Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland.

Authors:  H Seppälä; A Nissinen; Q Yu; P Huovinen
Journal:  J Antimicrob Chemother       Date:  1993-12       Impact factor: 5.790

5.  Stepwise acquisition of multiple drug resistance by beta-hemolytic streptococci and difference in resistance pattern by type.

Authors:  Y Miyamoto; K Takizawa; A Matsushima; Y Asai; S Nakatsuka
Journal:  Antimicrob Agents Chemother       Date:  1978-03       Impact factor: 5.191

6.  Decline of erythromycin resistance of group A streptococci in Japan.

Authors:  K Fujita; K Murono; M Yoshikawa; T Murai
Journal:  Pediatr Infect Dis J       Date:  1994-12       Impact factor: 2.129

7.  In vitro susceptibility of recent North American group A streptococcal isolates to eleven oral antibiotics.

Authors:  K M Coonan; E L Kaplan
Journal:  Pediatr Infect Dis J       Date:  1994-07       Impact factor: 2.129

8.  Mother-to-infant vertical transmission and cross-colonization of Streptococcus pyogenes confirmed by DNA restriction fragment length polymorphism analysis.

Authors:  E Bingen; E Denamur; N Lambert-Zechovsky; C Boissinot; N Brahimi; Y Aujard; P Blot; J Elion
Journal:  J Infect Dis       Date:  1992-01       Impact factor: 5.226

9.  Typing of group A streptococci by random amplified polymorphic DNA analysis.

Authors:  H Seppälä; Q He; M Osterblad; P Huovinen
Journal:  J Clin Microbiol       Date:  1994-08       Impact factor: 5.948

10.  Evaluation of methods for epidemiologic typing of group A streptococci.

Authors:  H Seppälä; J Vuopio-Varkila; M Osterblad; M Jahkola; M Rummukainen; S E Holm; P Huovinen
Journal:  J Infect Dis       Date:  1994-03       Impact factor: 5.226

View more
  30 in total

1.  Mechanisms of macrolide resistance in clinical pneumococcal isolates in France.

Authors:  F Fitoussi; C Doit; P Geslin; N Brahimi; E Bingen
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

2.  Susceptibility to telithromycin in 1,011 Streptococcus pyogenes isolates from 10 central and Eastern European countries.

Authors:  Kensuke Nagai; Peter C Appelbaum; Todd A Davies; Linda M Kelly; Dianne B Hoellman; Arjana Tambic Andrasevic; Liga Drukalska; Waleria Hryniewicz; Michael R Jacobs; Jana Kolman; Jolanta Miciuleviciene; Marina Pana; Lena Setchanova; Marianne Konkoly Thege; Helena Hupkova; Jan Trupl; Pavla Urbaskova
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

3.  Mechanisms of macrolide resistance in clinical group B streptococci isolated in France.

Authors:  F Fitoussi; C Loukil; I Gros; O Clermont; P Mariani; S Bonacorsi; I Le Thomas; D Deforche; E Bingen
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

4.  Azithromycin versus Penicillin in Acute Group A Streptococcal Tonsillopharyngitis.

Authors:  Itzhak Brook
Journal:  Curr Infect Dis Rep       Date:  2003-06       Impact factor: 3.725

5.  Genetic basis of antibiotic resistance in Streptococcus agalactiae strains isolated in a French hospital.

Authors:  Claire Poyart; Laurence Jardy; Gilles Quesne; Patrick Berche; Patrick Trieu-Cuot
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

6.  Macrolide resistance determinants of invasive and noninvasive group B streptococci in a Turkish hospital.

Authors:  Ziya Cibali Acikgoz; Ebru Almayanlar; Sohret Gamberzade; Safiye Gocer
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

Review 7.  Molecular detection of the macrolide efflux gene: to discriminate or not to discriminate between mef(A) and mef(E).

Authors:  Corné H W Klaassen; Johan W Mouton
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

8.  Association between resistance to erythromycin and the presence of the fibronectin binding protein F1 gene, prtF1, in Streptococcus pyogenes isolates from German pediatric patients.

Authors:  Maria Haller; Kirsten Fluegge; Sandra Jasminder Arri; Brit Adams; Reinhard Berner
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

9.  Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae and S. pyogenes.

Authors:  K Nagai; T A Davies; L M Ednie; A Bryskier; E Palavecino; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

10.  Emergence of macrolide-resistant Streptococcus pyogenes strains in French children.

Authors:  Edouard Bingen; Philippe Bidet; Liliana Mihaila-Amrouche; Catherine Doit; Samuel Forcet; Naïma Brahimi; Anne Bouvet; Robert Cohen
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.